EVOGENE LTD
EVGN · NASDAQ
Updated at 2026-10-14 09:31:18
- Today's High
- $0.39
- Today’s Low
- $0.37
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.39
- Previous Close
- $0.38
- Volume
- 106.18K
- Market Cap
- $6.1M
- P/E Ratio
- --
- EPS
- $-0.91
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 13 GAD FEINSTEIN STREET, REHOVOT, ISRAEL, 7638517
- Country
- IL
- Listing Date
- 2007-06-11
- Fiscal Year End
- December
- Shares Outstanding
- 13.59M
- CIK
- 0001574565
- Website
- evogene.com
Evogene Ltd., is a computational biology company. The company is headquartered in Rehovot, Israel.
Financial Metrics
Revenue
2026-06-30
$347K
2026-03-31
$334K
2025-12-31
$314K
2025-09-30
$312K
Operating Expenses
2026-06-30
$2.43M
2026-03-31
$3.35M
2025-12-31
$3.24M
2025-09-30
$2.87M
Net Income
2026-06-30
-$1.76M
2026-03-31
-$5.87M
2025-12-31
-$5.3M
2025-09-30
$3.87M
Net Profit Margin
2026-06-30
-509.51%
2026-03-31
-1.75K%
2025-12-31
-1.69K%
2025-09-30
1.24K%
Earnings Per Share
2026-06-30
$-0.13
2026-03-31
$-0.61
2025-12-31
$-0.61
2025-09-30
$-0.46
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$2.29M
2026-03-31
-$1.82M
2025-12-31
-$6.45M
2025-09-30
-$1.99M
Effective Tax Rate
2026-06-30
--
2026-03-31
-0.06%
2025-12-31
--
2025-09-30
-0.03%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $347K | $334K | $314K | $312K |
| Operating Expenses | $2.43M | $3.35M | $3.24M | $2.87M |
| Net Income | -$1.76M | -$5.87M | -$5.3M | $3.87M |
| Net Profit Margin | -509.51% | -1.75K% | -1.69K% | 1.24K% |
| Earnings Per Share | $-0.13 | $-0.61 | $-0.61 | $-0.46 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$2.29M | -$1.82M | -$6.45M | -$1.99M |
| Effective Tax Rate | -- | -0.06% | -- | -0.03% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.